Overcoming Clinical Inertia in Diabetes: Start with the Guidelines
This activity provides an overview of the current diabetes guidelines and the challenge of clinical inertia when caring for patients with diabetes. The use of individualized therapy will be explained. Optimization of therapy will then be discussed based on glycemic profiles, adverse effects, and safety.
Agenda
Welcome and Introductions
Curtis Triplitt, Pharm.D.
Start with the Guidelines
Eric L. Johnson, M.D.
Overcoming Clinical Inertia
Curtis L. Triplitt, Pharm.D.
Faculty Discussion and Audience Questions
Learning Objectives
- Review the current treatment guidelines for type 2 diabetes mellitus.
- Describe approaches to improve glycemic control including the use of stepwise and combination therapy.
- Discuss clinical inertia and barriers to achieving treatment goals.
Target Audience
This activity was planned to meet the educational needs of physicians, pharmacists, nurse practitioners, and physician assistants caring for patients with type 2 diabetes mellitus.
Format
This online activity consists of slide presentations, active learning, an assessment, and evaluation. view the system requirements.
Disclosures
In accordance with ACCME and ACPE Standards for Commercial Support, ASHP policy requires that all faculty, planners, reviewers, staff, and others in a position to control the content of this presentation disclose their financial relationships.
In this activity, only the individual/s below has disclosed a relevant financial relationship. No other persons associated with this presentation have disclosed any relevant financial relationships.
Curtis L. Triplitt
- AstraZeneca; Boehringer Ingelheim/ Eli Lilly; Janssen - Speakers Bureau
- Merck - Consultant
Eric L. Johnson
- Medtronic - Speakers Bureau
- Novo Nordisk - Advisory Board, Speakers Bureau
- Sanofi - Advisory Board
Claim CE within 60 Days
Participants should claim CE credit for this home-study activity only if they have not claimed credit for the live activity.
To receive CE credit, complete the steps below within 60 days of completing the activity.
- View entire presentation and answer all polling questions.
- Click "Complete Activity" on the last slide to link to complete the assesment and evaluation.
- Verify credits were successfully transferred to CPE Monitor before the ACPE 60-day deadline by checking your NABP eProfile account.
After the 60-day deadline, ASHP will no longer be able to report credit(s).
CPE Information
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
ACPE #: 0204-0000-18-423-H01-P
Release Date: August 6, 2018
Expiration Date: May 31, 2020
Activity Type: Knowledge-based
CE Credits: 1.0 hour
Activity Fee: Free of charge
CME Information
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The American Society of Health-System Pharmacists designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.